Paper21990266
Clinical significance of NTRK family gene expression in neuroblastomas.
Light JE and 9 others. Pediatr Blood Cancer, 2012. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Clinical significance of NTRK family gene expression in neuroblastomas. Papers, record 21990266. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21990266
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Nerve Growth Factors | Major topic |
| Neuroblastoma | Major topic |
| Nuclear Proteins | Major topic |
| Oncogene Proteins | Major topic |
| Receptor, Nerve Growth Factor | Major topic |
| Receptor, trkA | Major topic |
| Humans | |
| Infant | |
| N-Myc Proto-Oncogene Protein | |
| Prognosis | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Survival Rate |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA097323 | NCI NIH HHS | United States | P01CA097323 | PubMed and NIH | NIH RePORTER |
| U10 CA098413 | NCI NIH HHS | United States | U10CA098413 | PubMed and NIH | NIH RePORTER |
| P01-CA097323 | NCI NIH HHS | United States | P01CA097323 | PubMed and NIH | NIH RePORTER |
| R01 CA094194 | NCI NIH HHS | United States | R01CA094194 | PubMed and NIH | NIH RePORTER |
| T32 CA009615 | NCI NIH HHS | United States | T32CA009615 | PubMed and NIH | NIH RePORTER |
| R01-CA094194 | NCI NIH HHS | United States | R01CA094194 | PubMed and NIH | NIH RePORTER |
| R01 CA140198 | NCI NIH HHS | United States | R01CA140198 | PubMed and NIH | NIH RePORTER |
| U10 CA98413-06 | NCI NIH HHS | United States | U10CA984130 | PubMed | NIH RePORTER |
| R01 CA140198-01 | NCI NIH HHS | United States | R01CA140198 | PubMed and NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20003389 | c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients. | BMC Cancer | 2009 | https://conductscience.org/library/papers/20003389 | PubMed |
| 2 | 21419569 | The effect of P75 on Trk receptors in neuroblastomas. | Cancer Lett | 2011 | https://conductscience.org/library/papers/21419569 | PubMed |
| 3 | 8433391 | Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. | J Natl Cancer Inst | 1993 | https://conductscience.org/library/papers/8433391 | PubMed |
| 4 | 2066755 | Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/2066755 | PubMed |
| 5 | 8552397 | Expression of TrkC in favorable human neuroblastomas. | Oncogene | 1996 | https://conductscience.org/library/papers/8552397 | PubMed |
| 6 | 20960503 | The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan. | Cancer | 2011 | https://conductscience.org/library/papers/20960503 | PubMed |
| 7 | 10200344 | Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma. | Int J Oncol | 1999 | https://conductscience.org/library/papers/10200344 | PubMed |
| 8 | 8336186 | Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8336186 | PubMed |
| 9 | 16778177 | Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. | Cancer Res | 2006 | https://conductscience.org/library/papers/16778177 | PubMed |
| 10 | 10550322 | Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10550322 | PubMed |
| 11 | 10784629 | Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. | J Clin Oncol | 2000 | https://conductscience.org/library/papers/10784629 | PubMed |
| 12 | 20179224 | Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20179224 | PubMed |
| 13 | 7700353 | A BDNF autocrine loop in adult sensory neurons prevents cell death. | Nature | 1995 | https://conductscience.org/library/papers/7700353 | PubMed |
| 14 | 8264643 | Expression and function of TRK-B and BDNF in human neuroblastomas. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/8264643 | PubMed |
| 15 | 12438236 | Resistance to chemotherapy mediated by TrkB in neuroblastomas. | Cancer Res | 2002 | https://conductscience.org/library/papers/12438236 | PubMed |
| 16 | 7789988 | Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2). | Genomics | 1995 | https://conductscience.org/library/papers/7789988 | PubMed |
| 17 | 6719137 | Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. | Science | 1984 | https://conductscience.org/library/papers/6719137 | PubMed |
| 18 | 21129533 | Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute. | J Pediatr Surg | 2010 | https://conductscience.org/library/papers/21129533 | PubMed |
| 19 | 10589776 | Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10589776 | PubMed |
| 20 | 8441429 | Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8441429 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41979602 | Comparative ASCL1 Interactome Analysis Reveals CDK2-Cyclin A2 as Suppressors of Differentiation in MYCN-Amplified Neuroblastoma. | Mol Cancer Res | 2026 | https://conductscience.org/library/papers/41979602 | PubMed |
| 41581152 | Oncogenic influences of neurotrophin receptors: Shedding light on Trk biology. | Cell Rep | 2026 | https://conductscience.org/library/papers/41581152 | PubMed |
| 40875081 | NTRK expression and its clinical significance in pancreatic neuroendocrine tumors. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40875081 | PubMed |
| 39452455 | NTRK Gene Expression Analysis in Oral Squamous Cell Carcinoma Mexican Population. | Dent J (Basel) | 2024 | https://conductscience.org/library/papers/39452455 | PubMed |
| 38413795 | AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis. | Oncogene | 2024 | https://conductscience.org/library/papers/38413795 | PubMed |
| 38398114 | A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38398114 | PubMed |
| 38357305 | From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38357305 | PubMed |
| 37460933 | Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37460933 | PubMed |
| 37456561 | Case report: Molecular characterisation of adipose-tissue derived cells from a patient with ROHHAD syndrome. | Front Pediatr | 2023 | https://conductscience.org/library/papers/37456561 | PubMed |
| 35149717 | ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. | Sci Rep | 2022 | https://conductscience.org/library/papers/35149717 | PubMed |
| 33963905 | Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/33963905 | PubMed |
| 31979374 | NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31979374 | PubMed |
| 31681584 | Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia. | Front Oncol | 2019 | https://conductscience.org/library/papers/31681584 | PubMed |
| 30675270 | Targeting the BDNF/TrkB pathway for the treatment of tumors. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30675270 | PubMed |
| 30135355 | Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro. | Nutrients | 2018 | https://conductscience.org/library/papers/30135355 | PubMed |
| 29617282 | Inhibiting TRK Proteins in Clinical Cancer Therapy. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29617282 | PubMed |
| 28871274 | Paired Expression Analysis of Tumor Cell Surface Antigens. | Front Oncol | 2017 | https://conductscience.org/library/papers/28871274 | PubMed |
| 25884760 | Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/25884760 | PubMed |
| 25164011 | MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival. | Cancer Res | 2014 | https://conductscience.org/library/papers/25164011 | PubMed |
| 24947929 | PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24947929 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21990266
GET https://conductscience.org/api/papers/v1/21990266/references?page=2